This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Reference

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Committee on Safety of Medicines (1996). Oesophageal reactions with alendronate sodium (Fosamax). Current Problems in Pharmacovigilance, 22, 5.

Liberman UA et al (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. NEJM, 333, 1437-43.

Osteoporosis Clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. Royal College of Physicians, Bone and Tooth Society of Great Britain July 2000

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.